Moderna, Inc. (NASDAQ:MRNA) will be hosting a conference call at 8:00 AM eastern time on 29th October 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.modernatx.com
Earnings Expectation
Moderna, Inc. is expected to report third quarter earnings results, before market open, on Thursday 29th October 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.43 per share from revenue of $ 77.51 million. Looking ahead, the full year loss are expected at $ 1.46 per share on the revenues of $ 309.22 million.
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. It has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation.
